 Sohail Khan
| Title | Director |
|---|
| Institution | Cherokee Nation Health Services |
|---|
| Department | Health Services |
|---|
| Address | 22361 Bald Hill Road
Tahlequah OK
|
|---|
| Phone | 918/454-5000 |
|---|
| vCard | Download vCard |
|---|
|
|
|
 Research S06GM123546 (KHAN, SOHAIL)Sep 15, 2017 - Jul 31, 2021 NIH
Cherokee Nation Native American Research Center for Health
Role: Principal Investigator |
| P20CA202923 (KHAN, SOHAIL)Sep 24, 2015 - Aug 31, 2019 NIH
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
Role: Principal Investigator |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Wang W, Blackett P, Khan S, Lee E. Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee. J Lipids. 2017; 2017:8236325. PMID: 28473926.
-
Blackett PR, Khan S, Wang W, Alaupovic P, Lee ET. Sex differences in HDL ApoC-III in American Indian youth. Biol Sex Differ. 2012 Aug 16; 3(1):18. PMID: 22898077; PMCID: PMC3526514.
-
Gaddy JR, Vista ES, Robertson JM, Dedeke AB, Roberts VC, Klein WS, Levin JH, Mota FH, Cooper TM, Grim GA, Khan S, James JA. Rheumatic disease among Oklahoma tribal populations: a cross-sectional study. J Rheumatol. 2012 Oct; 39(10):1934-41. PMID: 22896022; PMCID: PMC3468952.
-
Wang W, Khan S, Blackett P, Alaupovic P, Lee E. Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes. J Clin Lipidol. 2013 Jan-Feb; 7(1):38-42. PMID: 23351581; PMCID: PMC3558999.
-
Kelly D, Squire IB, Khan SQ, Dhillon O, Narayan H, Ng KH, Quinn P, Davies JE, Ng LL. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction. Am J Cardiol. 2010 Aug 15; 106(4):477-82. PMID: 20691304.
-
Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J. 2009 May; 30(9):1057-65. PMID: 19168526.
-
Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2008 May 13; 51(19):1857-64. PMID: 18466800.
-
Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007 Apr 24; 115(16):2103-10. PMID: 17420344.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2007 | 1 | | 2008 | 1 | | 2009 | 1 | | 2010 | 1 | | 2012 | 3 | | 2017 | 1 |
To return to the timeline, click here.
|
Khan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|